Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China · Delayed Price · Currency is CNY 3.270
-0.020 (-0.61%)
At close: Feb 13, 2026
SHE:002589 Revenue
Realcan Pharmaceutical Group had revenue of 1.86B CNY in the quarter ending September 30, 2025, a decrease of -7.98%. This brings the company's revenue in the last twelve months to 7.32B, down -8.38% year-over-year. In the year 2024, Realcan Pharmaceutical Group had annual revenue of 7.97B, down -0.85%.
Revenue (ttm)
7.32B
Revenue Growth
-8.38%
P/S Ratio
0.66
Revenue / Employee
2.53M
Employees
2,897
Market Cap
4.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.97B | -68.02M | -0.85% |
| Dec 31, 2023 | 8.03B | -4.28B | -34.74% |
| Jan 1, 2023 | 12.31B | -8.75B | -41.54% |
| Jan 1, 2022 | 21.06B | -6.17B | -22.67% |
| Dec 31, 2020 | 27.23B | -8.02B | -22.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.54B |
| China National Accord Medicines Corporation | 73.04B |
| China National Medicines Corporation | 51.95B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |